Press "Enter" to skip to content

New patent expiration for Viiv Hlthcare drug JULUCA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Viiv Hlthcare drug JULUCA

Annual Drug Patent Expirations for JULUCA
Annual Drug Patent Expirations for JULUCA

Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.

JULUCA drug price trends.

Drug patent litigation for JULUCA.

This drug has four hundred and nine patent family members in fifty-five countries.

The generic ingredient in JULUCA is dolutegravir sodium; rilpivirine hydrochloride. One supplier is listed for this compound. Additional details are available on the dolutegravir sodium; rilpivirine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Viiv Hlthcare drug JULUCA
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions